Photo via Just The News

Pro-life orgs urge transparency, accuracy in FDA abortion drug review

Read the original at Just The News ↗
Cite

The Center Square Staff. (2026, November 13). Pro-life orgs urge transparency, accuracy in FDA abortion drug review. Just The News. https://justthenews.com/nation/states/center-square/pro-life-orgs-urge-transparency-accuracy-fda-abortion-drug-review?utm_source=justthenews.com&utm_medium=feed&utm_campaign=external-news-aggregators

Dated from the outlet's own feed. Check the original for its byline.

Just The News · collected 2026-11-16 · by The Center Square Staff

Quick Summary

Two pro-life organizations, the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG) and the Charlotte Lozier Institute (CLI), submitted a Citizens’ Petition to the FDA, urging the agency to ensure transparency, seek input from outside experts, and use accurate and relevant data in its review of the abortion drug mifepristone. Dr. Christina Francis, CEO of AAPLOG, expressed concern that the FDA’s safety review will be ineffective if based on inadequate data, and emphasized the importance of a thorough, unbiased assessment to ensure public trust in FDA guidance.
Written by AI on 2026-11-16, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

The American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG) and the Charlotte Lozier Institute (CLI) submitted a Citizens' Petition to the FDA on November 13, 2026, urging the agency to include accurate and relevant data in its review of abortion drugs and to invite input from outside experts. Dr. Christina Francis, CEO of AAPLOG, stated that the FDA's safety review will be "worthless" if it relies on inadequate and incomplete data sets. The petitioners have been studying and contributing to medical literature regarding mifepristone abortions for the past 30 years and expressed grave concerns about the FDA's approach to its promised safety review.

Written for “FDA Abortion Drug Review” on 2026-11-22, grounded in this article and the 0 other(s) covering the same event.

Compared with similar articles

This article reads leans strongly right and hedges 0% of its claims. Each row says how that neighbour differs.
Mother Jones
Hedges 2 of 41 claims Outlet record 60/100
“The articles discuss different aspects of pro-life activism: one focuses on a petition for transparency in FDA reviews, while the other addresses the aftermath of midterm elections and pressure on the GOP.”
Fox News
Leans strongly right Hedges 2 of 17 claims Outlet record 66/100
“The articles describe different initiatives related to the FDA's review of abortion drugs, with Article A focusing on a commitment by Dr. Heidi Overton in response to Senator Hawley's pressure, while Article B discusses petitions from pro-life organizations for transparency and accuracy in the review.”
Washington Examiner
Leans strongly right Hedges 1 of 3 claims Outlet record 67/100
“The articles discuss related topics but describe different events: one focuses on the Senate's potential questioning of Heidi Overton about abortion drugs, while the other reports on pro-life organizations submitting a petition to the FDA for transparency in the abortion drug review process.”

Story

FDA Abortion Drug Review
Health · 1 article(s) covering the same event.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
20
sentences that state something as happening or true
Uncertain
0%
0 of 20 hedged ("reportedly", "may", "according to")
Leaning
Leans strongly right
of the writing, not the subject · beta estimate
Publisher signals
59/100
Just The News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-16 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Just The News · 905 article(s) · 2 correction(s) detected
Running correction rate · 2 correction(s)

Who wrote this

The Center Square Staff
133 article(s) here · 1 carrying a prediction
Crowley blamed the One Big Beautiful Bill Act for the decision, saying that Wisconsin could not afford to expand Medicaid without matching federal funds.
“Zacharia may have thought she was just playing a lawyer on TV, but by repeatedly holding herself out as an attorney on news programs, she was pretending to have authority she lacks,” said Michelle Kuppersmith, executive director of Campaign for Accountability.
Nonprofit analyst puts $4.9T price tag on Democrats' first 100 days Estimate includes $1.6 trillion to reverse the health provisions and $1.8 trillion in lost revenue from repealing the tariffs second-term Republican President Donald Trump has imposed The first 100 days planned activities by Democrats in the U.S. House of Representatives would cost taxpayers $4.1 trillion through 2037 and add $4.9 trillion to the debt with interest, according to a new analysis from the Committee for a Responsible Federal Budget. Democratic Leader Hakeem Jeffries, D-N.Y., Democratic nominee for speaker in the 120th Congress, laid out the agenda in a Nov. 4 letter to House Democrats.
Texas Democrat Gov.- elect Hinojosa likely to rescind CAIR terrorist designation Of the many executive orders outgoing Gov. Greg Abbott issued that Gov.-elect Gina Hinojosa is expected to rescind, one relates to the Council on American Islamic Relations.
Illegal workers may have been paid with federal contract money, report shows Federal contracting rules require businesses to use the E-Verify system to check a worker's permission to work in the United States.
Six Virginia residents and a nonprofit sued federal immigration officials, saying officers made arrests without warrants before determining whether each person was in the country unlawfully or was likely to escape before officers could get a warrant.
“People in power need to make sure that it's done quickly, though, and that it's done correctly, because the consequences of another screw-up could be disastrous,” Applebaum told The Center Square.
The state, she said, could work on the hospital situation with some of the $193 million it was awarded under the federal Rural Health Transformation Fund program.
Illinois is one of the states that received a D+ for maternal and infant health on an annual report card, but recent policy changes might improve the state’s grade. March of Dimes Chief Medical and Health Officer Dr. Michael Warren, said Illinois could move up after the state mandated coverage of biomarker screening for women on Medicaid. “You've extended Medicaid coverage to populations that are not pregnant yet, improving health even before pregnancy and then when women are pregnant, extending that coverage out for a full year,” Warren said.
Illinois is one of the states that received a D+ for maternal and infant health on an annual report card, but recent policy changes might improve the state’s grade. March of Dimes Chief Medical and Health Officer Dr. Michael Warren, said Illinois could move up after the state mandated coverage of biomarker screening for women on Medicaid. “You've extended Medicaid coverage to populations that are not pregnant yet, improving health even before pregnancy and then when women are pregnant, extending that coverage out for a full year,” Warren said.
Wire or desk byline, not an individual reporter.
Also by The Center Square Staff
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 133 articles by The Center Square Staff →

Topics

American FDA The Center Center The Center Square the American Association of Pro-Life Obstetricians and Gynecologists

Subjects

FDA ORG · 16× Francis PERSON · 8× American NORP · 3× The Center Square ORG · 2× the American Association of Pro-Life Obstetricians and Gynecologists ORG · 2× AAPLOG ORG · 1× Christina Francis PERSON · 1× The Center Center ORG · 1× the Charlotte Lozier Institute ORG · 1× the U.S. Food and Drug Administration ORG · 1×

Narrative

The American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG) along with the Charlotte Lozier Institute (CLI) urged the FDA in their Citizens’ Petition to include relevant and accurate data in the review, invite the input of outside sources for the review, and provide maximum transparency “regarding the design, conduct, and evaluation of the review.”
framing: assertive · carried by 1 article(s) · first seen 2026-11-16
Pro-life orgs urge transparency, accuracy in FDA abortion drug review Francis said the FDA's safety review will be worthless if it relies on inadequate and incomplete data sets.
2026-11-16 · Just The News
Pro-life orgs urge transparency, accuracy in FDA abortion drug review · assertive framing

Claims (20 extracted, 0 hedged)

Pro-life orgs urge transparency, accuracy in FDA abortion drug review Francis said the FDA's safety review will be worthless if it relies on inadequate and incomplete data sets. asserted
it → urge → sets
Two pro-life organizations submitted a Citizens’ Petition to the U.S. Food and Drug Administration, urging the agency to seek transparency, input from outside experts, and accurate and relevant data in its promised abortion drug review. asserted
organizations → submit → review
Dr. Christina Francis, CEO of one of the petitioning groups – the American Association of Pro-Life Obstetricians and Gynecologists – told The Center Square that “the FDA must answer the medical community's call and give the American people the comprehensive safety review they deserve.” asserted
they → petition → review
Francis’ organization “and its members have spent the last 30 years both studying and contributing to the medical literature regarding mifepristone abortions,” she said. asserted
she → spend → abortions
“As experts in this area, we have grave concerns about how the FDA (per its own report) appears to be conducting its long-promised safety review of the abortion drug.” asserted
FDA → have → drug
Francis said the FDA's safety review will be worthless if it relies on inadequate and incomplete data sets. asserted
it → say → sets
“We laid out in our citizens' petition exactly how the FDA can correct this and why it should,” Francis said. asserted
Francis → lay → this
The American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG) along with the Charlotte Lozier Institute (CLI) urged the FDA in their Citizens’ Petition to include relevant and accurate data in the review, invite the input of outside sources for the review, and provide maximum transparency “regarding the design, conduct, and evaluation of the review.” asserted
Association → urge → review
“Petitioners do not ask FDA to reach any particular conclusion regarding mifepristone's safety profile,” the petition said. asserted
petition → ask → profile
“Rather, Petitioners ask FDA to ensure that its review relies upon the most complete datasets, the most rigorous methodologies, and the greatest possible transparency.” asserted
review → ask → datasets
A safety review of the abortion drug mifepristone was promised in 2025. asserted
review → promise → 2025
In December 2025, pro-life organizations called out the FDA and its then-commissioner Marty Makary for having “slow-walked” its promised abortion drug review, as SBA Pro-Life America termed it. asserted
America → call → it
The FDA has not yet responded to The Center Square’s request for comment. asserted
FDA → respond → comment
Francis told The Center Square that “the FDA is tasked with ensuring that the medications it approves, and the conditions for their use, are safe for the American public. asserted
it → tell → public
“Physicians, like myself, are guided in how we counsel patients partly by FDA guidance,” Francis said. asserted
Francis → guide → guidance
“American women and girls need to be able to trust that this guidance is based on thorough, accurate, and unbiased data collection and assessment.” asserted
guidance → need → collection
Francis told The Center Square that her clinical experience “as well as that of our thousands of members, confirms what the FDA should have known before it removed the in-person dispensing requirement for abortion drugs: that these extremely high-risk drugs should never be given without medical supervision.” asserted
drugs → tell → supervision
The number of in-person visits required to obtain the abortion pill were reduced under the Obama administration and done away with under Biden, The Center Square reported. asserted
Square → require → Biden
Francis said that “the FDA knew and admitted” doing away with in-person dispensing requirements “would cause more emergencies for women, and it did it anyway – and women and their preborn children are paying the price.” asserted
women → say → price
The Center Square reported at the beginning of October that the FDA set a deadline of March 2027 for its mifepristone review to be complete by. asserted
review → report → March
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support